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Abstract 17 
In addition to the canonical right-handed double helix, several noncanonical deoxyribonucleic acid 18 
(DNA) secondary structures have been characterised, including quadruplexes, triplexes, 19 
slipped/hairpins, Z-DNA and cruciforms collectively termed non-B DNA. The formation of these 20 
structuresnon-B DNA is mediated by repetitive sequence motifs, such as G-rich sequences, 21 
purine/pyrimidine tracts, direct (tandem) repeats, alternating purine–pyrimidines and inverted repeats, 22 
respectively. Such repeats are abundant in the human genome and non-B DNA has been are found in 23 
association withat specific classes of genesgenomic locations, supporting a role for them in gene 24 
regulation, RNA translation and  or protein function. Repetitive sequence motifs are also commonly 25 
found at sites of chromosomal alterations associated with both human genetic disease and cancer. , 26 
including gross rearrangements and copy number variations (CNVs) associated with both disease and 27 
phenotypic variation. Finally, variable number tandem repeats (VNTRs) or microsatellites are present 28 
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in many gene regulatory regions. Characterised by an inherent capacity to expand spontaneously, such 1 
sequences are not only known to cause >30 neurological diseases but may also contribute to human 2 
disease susceptibility. The formation of alternative non-B DNA structures is believed to promote 3 
genomic alterations by impeding efficient DNA replication, transcription, and repair. 4 
Key Concepts:  5 
 The structure of DNA is polymorphic as well as its sequence; in addition to the 6 
canonical right-handed double helix (B-DNA), repetitive sequences can also adopt alternative 7 
(non-B DNA) conformations such as quadruplexes, triplexes, slipped/hairpins, Z-DNA and 8 
cruciforms. 9 
 Repetitive DNA sequences are found at locations within many human genes that 10 
suggest they can either affect transcription or alternatively encode homopolymeric amino acid 11 
runs that could be important for either protein–protein or protein–DNA/RNA interactions. 12 
 The integrity of the Y-chromosome depends on large inverted repeats, which have the 13 
capacity to form cruciform structures that may potentiate intrachromosomal recombination.G4 14 
and Z-DNA strucutures have been detected in cells through specific antibodies, mostly in 15 
correspondence of actively transcribed genes and, in the case of G4, at telomeres. 16 
 Copy number variation (CNV) is a form of genetic alteration that, by involving 17 
thousands of loci in the genome, contributes to human individuality. 18 
 Repetitive sequences capable of forming non-B DNA are found at sites of 19 
chromosomal breaks, CNVs and other rearrangements such as translocations, deletions and 20 
gene conversion events, which can contribute to human genetic disease and cancer. 21 
 The recurrent translocation t(22;11) events associated with Emanuel syndrome are 22 
mediated by cruciform structures that occur at inverted repeats. 23 
 Tandem repeats (microsatellites) may expand within gene sequences, contributing to 24 
more than 30 neurological diseases; . Ppresent in variable number in genes in the population, 25 
they may contribute to human disease susceptibility. 26 
 An increasing number of enzymes are being discovered that resolve non-B DNA 27 
structures, and whose mutations lead to genomic instability and human disease. 28 
 Experiments in model systems and bioinformatic analyses support the conclusion that 29 
repetitive sequences trigger genomic instability by adopting non-B DNA 30 
conformationslncRNAs repress gene expression by forming triplex structures with their target 31 
duplex DNA. 32 
 Non-B DNA structures stimulate mutations via mechanisms that alter DNA synthesis, 33 
trascription and repair. 34 
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Abstract: Please expand the abstract to 120 – 150 words 17 
Key Concepts: Please include up to ten key concepts in your manuscript. Key concepts 18 
should sum up the essential ideas in the manuscript, rather than listing the article 19 
contents. Key concepts should not be confused with key words (which are for indexing 20 
purposes) or glossary. A key concept should be described in a short sentence and should 21 
be presented in bullet style, e.g.  22 
 Animal behaviorists must participate in conservation planning to protect the 23 
future of biodiversity. 24 
 Lipid bilayers provide the fundamental architecture of biological membranes. 25 
 26 
Introduction  27 
Soon after the discovery that deoxyribonucleic acid (DNA) was an antiparallel right-handed double 28 
helix (Watson and Crick, 1953), work on synthetic single-stranded DNA molecules of defined 29 
sequence composition revealed the formation of a three-stranded structure, in addition to the expected 30 
duplex (Felsenfeld and Rich, 1957). This implied the existence of more than one type of DNA 31 
conformation. During the subsequent 50 60 years, the repertoire of conformations in which synthetic 32 
DNA molecules of repeating sequence composition were found to assemble, increased steadily. To 33 
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date, several unique DNA structures, quite distinct from the canonical B-form, have been 1 
characterised, including left-handed Z-DNA, cruciforms, looped-out or slipped folds, parallel DNA, 2 
triplexes, quadruplexes and higher-order arrangements. These conformations are collectively called 3 
non-B DNA. 4 
In parallel to these biophysical investigations, DNA sequencing has revealed the existence in 5 
chromosomes of several different types of repetitive motifs known to adopt non-B forms in vitro 6 
(Christophe et al., 1985; Lyamichev et al., 1985; Wells et al., 1988), spurring speculation as to their 7 
biological function. Pioneering work in bacteria (Glickman and Ripley, 1984) suggested a role for 8 
non-B DNA-forming sequences in mediating chromosomal deletions in vivo. However, it was not 9 
until comparatively recently (Bacolla et al., 2004; Kurahashi and Emanuel, 2001; Repping et al., 10 
2002; Wang and Vasquez, 2004; Wells and Ashizawa, 2006) that the concept of DNA secondary 11 
structure as a promoter of genomic rearrangements acquired broad support. Critical to these 12 
developments was the discovery of microsatellite repeat diseases (MRDs), a novel class of 13 
neurological disorders caused by the expansion of triplet (and other) microsatellite repeats (Brouwer 14 
et al., 2009; Dion and Wilson, 2009; Lee and Cooper, 2009; Lopez Castel et al., 2010; Wells and 15 
Ashizawa, 2006). 16 
The completion of the human and other mammalian genome-sequencing projects (Lander et al., 2001) 17 
has made it possible to explore the frequencies and locations of chromosomal sites containing non-B 18 
DNA-forming sequences, as well as their evolutionary conservation in orthologous genomes. From a 19 
number of studies (reviewed in Zhao et al., 2010) it can could be concluded that such sites occur 20 
much more frequently than expected by chance alone and that different non-B DNA-forming motifs 21 
are are found in association with different genomic regions. Hence, a novel view of genome structure 22 
and function has emerged in which repetitive DNA, once regarded as ‘junk DNA’, participates in the 23 
regulation of genes, telomere maintenance, RNA metabolism, protein function and genome stability. 24 
The human genome sequencing project (HGSP) has also led to the realisation that many individual 25 
genomes exist (in contrast to the early concept of a nearly identical standard genome common to all 26 
human beings) in which a large number of gross variations involving duplicated and deleted regions 27 
(copy number variations or CNVs) comprising large (>1 kb in length, on average) segments of DNA 28 
distinguish one individual from another. More recently, chromatin immunoprecipitation techniques 29 
associated with high throughput DNA sequencing has made it possible to map directly non-B DNA 30 
structures in cells, and to begin identifying the protein complexes with which these structures interact 31 
and elicit their biological functions. Overall, non-B DNA structures are emerging as a powerful tool 32 
used by cells to regulate gene expression, RNA translation, and most likely other processes. At the 33 
same time, an increasing large repretoire of enzymes that recognize and resolve these structures are 34 
being identified, whose general role is to prevent their deleterious effects on genome stability. Hence, 35 
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non-B DNA (and RNA) structures may be regarded as a double egde sword, critical for biological 1 
function and at the same time a threath to genome integrity. The advent of array comparative genomic 2 
hybridisation (aCGH) techniques over the past few years has made it possible to screen the human 3 
genome for CNVs in genes/gene regions that either lead/predispose to disease or give rise to 4 
phenotypic variation in healthy individuals and populations. The picture emerging is that some forms 5 
of non-B DNA, along with other sequence signatures, have a role in promoting CNV formation. 6 
Indeed, these composite data suggest that cells may have exploited the dynamically polymorphic 7 
nature of DNA to create functional genomic diversity; at the same time, the instability of certain 8 
sequences can give rise to deleterious changes that lead, or predispose, to genetic instability and 9 
disease. 10 
Herein, we review the main forms of non-B DNA structure, outline their distributions of the 11 
underlying repetitive motifs in the human genome, and present recent selected work on the 12 
relationship between repetitive DNA sequences and human genetic disease as well as phenotypic 13 
variation that may predispose to disease. 14 
Non-B DNA Structures  15 
To date, at least five types of non-B DNA structures have been associated with human genetic 16 
disease: cruciform, triplex, slipped/hairpin DNA, quadruplex and Z-DNA (Figure 1). Most DNA 17 
sequences in the human genome exist in the B-form. However, repetitive sequences may also adopt 18 
alterative conformations as a consequence of multiple hydrogen bonding interactions between bases 19 
or, as in the case of Z-DNA, rotational freedom about the N-glycosidic bond of G residues. Triplex 20 
and quadruplex DNA also rely on additional hydrogen bonding donor and acceptor groups existing in 21 
purines (A and G). 22 
<FIGURE 1 NEAR HERE> 23 
Cruciform DNA  24 
Inverted repeats (IR), defined as a series of nucleotides followed on the same strand by their 25 
complementary bases and usually separated by a spacer, are required for cruciform formation (Figure 26 
1a). The term ‘complementary’ here refers to the fact that A always pairs with T whereas G always 27 
pairs with C in B-form DNA (so-called ‘Watson–Crick’ base-pairing). 28 
The IR symmetry makes it possible for the bases along the same strand of DNA to pair with each 29 
other, rather than with the complementary strand, thereby giving rise to a cross-shaped structure 30 
(Figure 1a). In solution, two interconvertible conformations have been observed: an extended 31 
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conformation, in which each cruciform arm occupies the vertex of a simple tetrahedron, and a closed 1 
conformation, in which the two pairs of arms lie almost parallel to each other. The closed 2 
conformation is favoured at physiological salt concentrations because of the shielding of negatively 3 
charged phosphates. Thus, it is considered a good approximation of cruciform (and Holliday junction) 4 
structures in vivo. 5 
Triplex DNA (H-DNA)  6 
Triplex DNA is a three-stranded structure in which a third (DNA or ribonucleic acid (RNA)) strand 7 
binds to B-DNA by occupying its wide major groove. Watson–Crick hydrogen bonds are not altered 8 
in H-DNA; rather, purine bases along one strand of duplex DNA engage the incoming third strand 9 
through Hoogsteen-hydrogen bonds using available exocyclic groups not involved in Watson–Crick 10 
interactions. This third strand may originate from a nearby sequence on the same molecule 11 
(intramolecular triplex) or from separate molecules (intermolecular triplex), comprising either RNA, 12 
DNA or exogenously added triplex-forming oligonucleotides (TFOs). Hence, triplex DNA requires a 13 
succession of purines on the same strand of DNA. Four types of Hoogsteen-hydrogen bonds typically 14 
occur: A:T, A:A, G:C+ (C+, protonated base) and G:G (Figure 1b and c), which yield two types of 15 
triplexes: a YRY type, in which the third strand is pyrimidine-rich (Figure 1c), and an RRY type, in 16 
which the third strand is purine-rich (Figure 1b). In intramolecular triplexes, a mirror repeat (MR) 17 
symmetry is required in duplex DNA, whereby bases from one repeat separate from the 18 
complementary strand and fold back onto the second repeat to engage in Hoogsteen pairing. This 19 
reaction requires energy, which can be provided by negative supercoiling. If it is the pyrimidine-rich 20 
strand that engages in Hoogsteen base-pairing (such as occurs at low pH), the third strand runs 21 
parallel to the purine-rich accepting strand; however, if it is the purine-rich strand that engages in 22 
Hoogsteen pairing (at neutral pH), the third strand runs antiparallel to the purine-rich accepting 23 
partner, as shown in Figure 1a. Under in vitro conditions that mimick the molecular crowding of the 24 
cell environment, DDR (D = DNA; R = RNA) triplexes appear to be most stable. 25 
Slipped/hairpin DNA  26 
The reiteration of bases, such as CTGCTGCTG, or direct repeats (DR), provides the basis for the 27 
bulging out of small loops in duplex DNA when, after separation of the complementary strands, the 28 
repeat array reanneals out-of-register. Thus, slipped DNA occurs during DNA replication and 29 
transcription, two processes that necessarily entail strand separation. An alternative source of small 30 
loops in DNA (particularly at mononucleotide runs, such as AAA) originates from stuttering or 31 
skipping during DNA replication. Slippage during DNA replication is believed to lead to large 32 
expansions of triplet repeat sequences, and hence represents an important mechanism of mutation 33 
associated with MRDs. In such cases, lLong looped-out sequences may fold into double helices 34 
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(hairpins) stabilised by mismatches, such as T•T base pairs (Zheng et al., 1996), in addition to the 1 
Watson–Crick A•T and G•C base pairs along the hairpins. 2 
Quadruplex (tetraplex, G4) DNA  3 
G4 DNA has received considerable attention during the past few years, in part because human 4 
telomeres, whose function is often dysregulated in cancer, are composed exclusively of hexameric 5 
(TTAGGG)n repeat sequences capable of forming this type of non-B DNA structure. For 6 
quadruplexes to form, the sequence pattern required comprises four closely spaced sets of 2–4 Gs, 7 
such as the 3-set GGG(n1)GGG(n2)GGG(n3)GGG, where n1, n2 and n3 represent 1–7 bases of any kind 8 
(loop). The basic unit in G4 DNA, a G-tetrad or G-quartet, comprises a planar array of four guanines 9 
(one from each of the four sets) connected to each other through Hoogsteen-type hydrogen bonds 10 
(Figure 1d). A core of at least two (three in the example shown in Figure 1a) G-quartets stack on top 11 
of one another, stabilised by cation coordination (potassium ion is most effective) between any two 12 
stacks while the loops provide strand connectivity along the edges of the stacked G-quartets. A high 13 
degree of structural polymorphism has been revealed, in which loops connect in a lateral, diagonal or 14 
chain reversal fashion, strands run parallel or antiparallel to one another, and guanine residues may 15 
adopt either the syn or the anti N-glycosidic conformation (Neidle, 2009; Figure 1a). Thus, competing 16 
conformations usually form in solution. The most common isomer, as evidenced by nuclear magnetic 17 
resonance (NMR) and X-ray crystallography, is represented by the (3+1) mixed topology, 18 
characterised by one chain reversal and two lateral loops and by a three syn plus one anti-19 
arrangement of guanines per G-tetrad (Neidle, 2009). 20 
Z-DNA  21 
Z-DNA is unusual among the non-B DNA structures in that strandedness is reversed by the rotation 22 
from the anti (in right-handed B-DNA) to the syn (in left-handed Z-DNA) conformation of every G 23 
residue within tracts of alternating GY (Y, pyrimidine) sequences, such as (GC)n or (GC)m(GT)n. In 24 
sharp contradistinction to B-DNA, which possesses both a major and a minor groove, Z-DNA is 25 
characterised by a single deep and narrow groove and an overall tube-like shape (Gessner et al., 26 
1989). X-ray crystallography has also shown that the base pairs located at the junctions between the 27 
B- and Z-sections (B-Z junctions, Figure 1a) have the tendency to flip out of the double-helix (Ha et 28 
al., 2005), thereby providing a substrate for base modification or cleavage (Burrows and Muller, 29 
1998). See also DNA Structure; DNA Structure: Sequence Effects; DNA Structure: Sequence Effects; 30 
Supercoiled DNA: Structure; Macromolecular Interactions: Aptamers; Base Pairing in DNA: Unusual 31 
Patterns. 32 
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Probing Non-B DNA Structures Genome-wide-1 
forming Repeats and Human Genes  2 
Substantial progress has been made in recent years in mapping non-B DNA structures throughout the 3 
human genome using chromatin immunoprecipitation followed by deep sequencing, i.e. ChIP-seq. G4 4 
DNA was probed in a human epidermal ketatinocyte cell line by a G4 structure-specific antibody 5 
(Hansel-Hertsch et al., 2016), which revealed >10,000 high-confidence peaks (i.e. G4 structures), 6 
98% of which coincided with nucleosome-depleted and accessible chromatin regions. G4-rich 7 
chromatin displayed higher transcripional activity than similar regions devoid of G4 DNA, implying 8 
that non-B DNA served to enhance gene transcription on a genome-wide scale. A parallel G4 DNA-9 
specific antibody was also employed in ChIP-seq experiments to demonstrate the enrichment of G4 10 
structures at human telomeres (Liu et al. 2016).  11 
Z-DNA has been probed using a synthetic peptide, termed Zaa, consisting of two Z domains from 12 
the human double-stranded RNA-specific adenosine deaminase (ADAR), which binds Z-DNA with 13 
high selectivity, further attached to FLAG, a protein tag recognized by FLAG-specific antibodies. A 14 
total of 391 high-confidence Zaa binding peaks were identified in Hela cells, mostly near the 15 
transcription start sites of actively transcribed genes (Shin et al., 2016). A recent and biologically 16 
important extension in the field has been the identification of triplexes formed between duplex DNA 17 
and single-stranded RNA from long noncoding RNAs (lncRNAs) using ChIP assays and a triplex-18 
specific antibody (Mondal et al., 2015). 19 
Besides direct probing of non-B DNA in cells, earlier bioinformatic analyses shed light on the 20 
location of non-B DNA-forming repeats in the human and other genomes, which revealed unexpected 21 
complexities. LCompletion of the HGSP (Lander et al., 2001) has made possible the search for 22 
repetitive non-B DNA sequences with the goal not only of determining their genome-wide 23 
distribution but also of elucidating their putative functional role(s). The first such study (Warburton et 24 
al., 2004) reported that large IRs (>100 kb) are present mostly on the sex chromosomes, with male-25 
specific genes and gene families essential for male fertility located at symmetrical positions along the 26 
IR arms (Table 1; Skaletsky et al., 2003). The maintenance of gene function, particularly for the Y-27 
chromosome that lacks a homologue for recombination, is believed to depend on the formation of 28 
large cruciform structures by IR sequences, which potentiate the correction of mutations and double-29 
strand breaks by intrachromosomal recombination (Lange et al., 2009; Rozen et al., 2003; Zhao et al., 30 
2010). 31 
<TABLE 1 NEAR HERE> 32 
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Quadruplex-forming motifs are strongly over-represented near (±500 bp) transcription start sites and 1 
at the 3′ end of genes (1/4 to 1/3 of ∼20 000 human genes) associated with regulatory functions, 2 
including proto-oncogenes, such as MYC, KRAS and KIT (Du et al., 2008; Huppert et al., 2008; Table 3 
1). Genome-wide gene expression analyses (Du et al., 2008; Fernando et al., 2009) support the 4 
conclusion that these sequences play an active role in transcriptional regulation through the formation 5 
of quadruplex structures (Figure 2a). 6 
<FIGURE 2 NEAR HERE> 7 
The first hint that lLong (≥250 bases in length) (>1 kb) runs of homopurines•homopyrimidines might 8 
exist in the human genome came from the sequencing of the polycystic kidney disease 1 (PKD1) gene 9 
(Van Raay et al., 1996). A total ofwere found in introns of 228 genes were subsequently found to 10 
contain such tracts (≥250 bases in length) in introns (reviewed in Zhao et al., 2010Bacolla et al., 11 
2006), and these genes disproportionatelymostly encodinged proteins with a function in cell 12 
communication and synaptic transmission of the nerve impulse (Table 1). These gene classes are also 13 
enriched in GGAA, GAAA and GGGA tetranucleotide repeats, which have the capacity to form 14 
stable triplexes and are characterised by unusually strong base stacking. Although these types of genes 15 
are generally weakly transcribed, (Zhao et al., 2010; Figure 2b), a high proportion of them is 16 
preferentially expressed in the brain. Thus, homopurines•homopyrimidines may play specific roles in 17 
brain-associated gene function and regulation. 18 
The distribution of short tandem repeats (slipped/hairpin DNA) in protein-coding sequences is 19 
dominated by triplet repeats encoding homopolymeric runs of specific amino acids, such as 20 
polyglutamine, in transcription factors and gene-regulatory proteins that bind DNA and RNA (Table 21 
1; Bacolla et al., 2008). Homopolymeric runs of amino acids are known to play critical roles in 22 
protein–protein and protein–DNA/RNA interactions (Liu et al., 2006) and their number at specific 23 
loci appears to increase as one progresses from the genomes of simpler species to the more complex. 24 
Thus, DNA slippage and hairpin/loop formation may have been exploited over evolutionary time as a 25 
means to acquire, or fine-tune, protein function. See also Genetic Variation: Polymorphisms and 26 
Mutations; Next Generation Sequencing Technologies and Their Applications; Advances in Next 27 
Generation Sequencing Technologies and Cancer Epigenomics; Long Noncoding RNAs and Cancer; 28 
Long Noncoding RNAs and Tumorigenesis; Chromosome Y; Y Chromosome; Disordered Proteins; 29 
Protein Aggregation and Human Disorders; Protein Disorder and Human Genetic Disease. 30 
 31 
DNA/RNA Structure, Phenotypic Variation and 32 
Genetic Human Disease  33 
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 1 
A number of studies have implicated the formation of non-B DNA conformations as a source of of 2 
genomic rearrangements causing human genetic disease, including Fabry disease (Kornreich et al., 3 
1990), mental retardation (Bonaglia et al., 2009; Rooms et al., 2007), ornithine transcarbamylase 4 
deficiency (Quental et al., 2009), blepharophimosis-ptosis-epicanthus inversus syndrome (Verdin et 5 
al., 2013), uniparental disomy 14(mat) (Bena et al., 2010) and spermatogenic failure (Repping et al., 6 
2002) among others (reviewed in Bacolla and Wells, 2004). As an example, Emanuel syndrome 7 
(MIM #609029), characterised by severe mental retardation, facial abnormalities and heart and kidney 8 
defects, is a rare disease caused by the inheritance of a supernumerary der(22) chromosome from a 9 
parent carrying a constitutional translocation between chromosomes 11 and 22 (t(11;22)(q23;q11)) 10 
(Figure 32). Cloning of the genomic regions involved in the translocation revealed that the 11 
breakpoints typically occurred within narrow regions loci on both chr11 and chr22, at the centre of 12 
large (∼450 bp on chr11 and ∼590 bp on chr22) IR structures comprising almost exclusively A and T 13 
bases. These recurring breaks, at the centre of specific IRs termed PATRR11 and PATRR22 14 
(palindromic AT-rich regions) respectively, are consistent with the formation of large cruciform 15 
structures on both chromosomes (Figure 32). Theis conclusion is supported by a number ofthe 16 
following observations (Kurahashi et al., 2010). First, the PATRR22 sequence was shown to be both 17 
polymorphic and intrinsically unstable in the general population, such that deletions and duplications 18 
reducing or disrupting IR symmetry were commonly observed. Analyses of t(11;22) frequencies in 19 
sperm cells from healthy individuals yielded an estimate of ∼1.5×10−5 for the full-length IR 20 
chromosomes, but an ∼10-fold reduction for those chromosomes in which IR symmetry was 21 
disrupted, implying that cruciform structures were responsible for promoting the translocation event. 22 
Second, fluorescence in situ hybridisation indicated that the 22q11 cluster was involved in additional 23 
translocations, including 17q11, 4q35.1, 1p21.2 and 8q24.1. In all cases, repetitive sequences with IR 24 
symmetry were detected on the partner chromosome, with translocation frequencies decreasing with 25 
decreasing length of the IR sequences. Thus, size (and hence stability) of cruciform structures 26 
correlates with the likelihood of chromosomal breaks. Third, experiments in which two plasmids, one 27 
containing the PATRR11 sequence and the other containing the PATRR22 sequence, were transfected 28 
in human cells in culture displayed recombination between PATRR11 and PATRR22. Taken together, 29 
these data support the conclusion that large cruciforms are extruded from the PATRR11 and 30 
PATRR22 sequences, which are then cleaved at the centre, generating double-stranded broken ends 31 
that are sealed, yielding the der(22) and der(11) chromosomes (Figure 32). 32 
<FIGURE 23 NEAR HERE> 33 
The number of identified human disorders associated with gains (duplications) and losses (deletions) 34 
of genetic material, types of mutation once believed to occur only rarely (Perry et al., 2008), has 35 
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increased considerably over the past few years (Zhang et al., 2010). The recent application of aCGH 1 
(Conrad et al., 2010; Perry et al., 2008) to patients afflicted with either single-gene disorders, such as 2 
the CFTR gene associated with cystic fibrosis (Quemener et al., 2010) and the NRXN1 gene linked to 3 
autism spectrum disorders (Chen et al., 2013),  or multigene disorders (Vissers et al., 2009; Zhang et 4 
al., 2010), indicates indicated that CNVs can also be involved in these conditions. Additional 5 
gGenome-wide studies support the conclusion that CNVs affect thousands of loci, contributing in all 6 
likelihood to the myriad phenotypic differences observed between individuals (Conrad et al., 2010; 7 
Perry et al., 2008). Bioinformatic analyses indicate that the density of repetitive DNA sequence motifs 8 
capable of adopting non-B DNA conformations is significantly higher at CNV breakpoints than the 9 
genome average, implying that the formation of local DNA secondary structure may represent a 10 
common common mechanism for CNV-mediated deletions, duplications and inversions (Conrad et 11 
al., 2010; Perry et al., 2008; Vissers et al., 2009; Chen et al., 2013)..). 12 
Gene conversion is a form of recombination that uses homologous DNA sequences to repair a double-13 
strand break (DSB) and involves the nonreciprocal transfer of DNA from a ‘donor’ (the intact 14 
homologous sequence) to an ‘acceptor’ (the broken DNA end) sequence. When such transfer 15 
inactivates functional genes, pathological consequences can ensue. A comprehensive meta-analysis 16 
(Chuzhanova et al., 2009) of the DNA sequences flanking the regions of DNA exchange in 27 known 17 
disease-associated gene conversion events indicated that non-B DNA-forming sequences, particularly 18 
IRs, and recombination-promoting motifs occurred more frequently than expected by chance alone. 19 
Hence, at least some gene conversion events may be initiated by DSBs at sites of non-B DNA 20 
structure. Non-B conformations have also been found to occur more often than expected by chance at 21 
sites of microlesions (base-pair substitutions and insertions and deletions <21 bp in length) from a 22 
large meta-analysis of >83,000 pathologycal mutations associated with human inherited disease 23 
(Kamat et al., 2015). G4-forming sequences were also found to be overprepresented at deletion 24 
breakpoints in mithocondrial DNA (Dong et al., 2014). Lymphocytes isolated from patients with mild 25 
cognitive impairement showed higher numbers of G4 DNA foci than healthy controls, and indeed G4 26 
DNA count by immunofluorescence has been proposed as a biomarker for cognitice diforders, such as 27 
Alzheimer’s disease (Francois M et al., 2016). Cockayne syndrome (CS), a fatal neudegenerative 28 
disease characterized by accelerated aging, impaired growth, hypersensitivity to sunlight, is caused by 29 
mutations in either the ERCC8 (CSA) or ERCC6 (CSB) genes; CS has recently been associated with 30 
the accumulation of non-B structures in mitochondrial DNA (Scheibye-Knudsen et al., 2016). 31 
A well-recognized area in which non-B DNA has been linked to human genetic disease is that of 32 
microsatellite repeat diseases (MRDs). MRDs represent a growing class of pathological conditions, 33 
currently numbering >30, caused by the expansion of tandem repeats, mostly trinucleotide repeats, 34 
within human genes (Table 2; Brouwer et al., 2009; Lopez Castel et al., 2010). In most cases, the 35 
formation of DNA secondary structures, including slipped/hairpin DNA, quadruplex G4 and triplex 36 
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structures is believed to drive the expansion process (Lopez Castel et al., 2010; Mirkin, 2007; Wells 1 
and Ashizawa, 2006). MRDs may be broadly classified into two types: type 1, in which expansions 2 
are large (usually hundreds of copies of the repeat) and occur in non protein-coding regions 3 
(untranslated and intronic) and type 2, in which expansions are less severe but occur in protein-coding 4 
regions thereby altering protein sequence. See also Chromosomal Genetic Disease: Structural 5 
Aberrations, and Segmental Duplications and Genetic Disease 6 
<TABLE 2 NEAR HERE> 7 
Type 1 MRDs  8 
In fragile X syndrome (FXS), a CGG repeat is expanded in the 5′ untranslated (UTR) region of the 9 
FMR1 gene. In Friedreich ataxia (FA), expansions of a GAA repeat occur in the first intron of the 10 
frataxin (FRDA) gene, whereas myotonic dystrophy (DM) is caused by the expansion of either a CTG 11 
repeat in the 3′ -UTR of the DMPK gene (myotonic dystrophy type 1, DM1) or a CCTG repeat in the 12 
first intron of the ZNF9 gene (myotonic dystrophy type 2, DM2). In amyotrophic lateral sclerosis with 13 
frontotemporal lobar degeneration (ALS-FTLD) and spinocerebellar ataxia 36 (SCA36), expansions 14 
involve the G4-forming GGGCC and GGCCTG exanucleotide repeats in the first intron of the 15 
C9orf72 and NOP56 genes, respectively (Table 2). 16 
In FXS and FA patients, repeat expansion is associated with histone markers specific for 17 
heterochromatin (i.e. nontranscribed DNA), including deacetylation of histones H3 and H4 and 18 
methylation of histone H3 at lysine 9 (H3K9me), supporting the notion that loss-of-function due to 19 
gene silencing is the likely mechanism responsible for these diseases. In the case of DM, most of the 20 
pathogenesis has been recapitulated in mouse models by experiments that show RNA gain-of-function 21 
and the altered activity of at least two proteins, MBLN1 (muscleblind-like 1) and CUGBP1 (CUG-22 
binding protein 1) (Figure 43).  23 
<FIGURE 4 3 NEAR HERE> 24 
MBNL1 is a key regulator of alternative splicing that binds to double-stranded RNA hairpins, 25 
including those formed by CUG repeats (Lee and Cooper, 2009). In cells from DM1 patients, most 26 
MBNL1 is found in discrete nuclear foci where it is sequestered by expanded CUG (or CCUG) 27 
hairpins. Several transcripts are aberrantly spliced in DM1 mouse models, including Clcn1 (chloride 28 
channel 1), Insr (insulin receptor) and Tnnt2 (cardiac troponin T). Thus, loss-of-function of MBLN1 29 
mediated by long RNA hairpins is thought to contribute to DM pathology (Figure 4a3a). The second 30 
protein affected, is CUGBP1, which binds single-stranded CUG repeats and becomes 31 
hyperphosphorylated by PKC (protein kinase C) on CUG/CCUG repeat expansion through an 32 
unknown mechanism. Activation of CUGBP1 exacerbates the splicing defects of MBNL1 deficiency. 33 
13 
 
It also increases the translation of embryonic transcripts, such as MEF2A, and prevents the decay of 1 
short-lived mRNAs, including c-FOS and TNF  (tumour necrosis factor alpha). The antagonistic 2 
activities of MBNL1 and CUGBP1 are critical for the shifts in alternative splicing that accompany the 3 
transition from the embryonic to the adult developmental stages; DM may therefore entail a reversal 4 
of this developmental pattern (Figure 4b3b). RNA gain-of-function is also thought to underlie the 5 
pathology of fragile X-associated tremor/ataxia syndrome (FXTAS), affecting older patients carrying 6 
moderate CGG expansions in the frataxin gene, as well as SCA8, SCA10 and SCA12 (Brouwer et al., 7 
2009).  FMRP, whose levels are strongly reduced in FXS, is a G4- and RNA-binding protein that 8 
inhibits translation of bound mRNA partners; in neurons, ~400 transcripts have been reported as 9 
potential FMRP binding targets. FMRP is also synthesized in situ in dendrites, where synaptic 10 
activation induces its dephosphorylation, which in turns releases the bound mRNAs and restores 11 
translation (Simone et al., 2015). Mounting evidence also supports a role for G4 and other RNA 12 
secondary stuctures in mRNA transport along neutires for local protein synthesis through their 13 
binding by FMRP and other proteins including TDP-43, FUS/TLS, hnRNPs, and ZBP1 (Ishiguro et 14 
al., 2016)). A gain-of-function pathology has been attributed to G4 structures in expanded C9orf72 15 
mRNAs, which by sequestering nucleolin and RNA-processing factors compromise ribosomal RNA 16 
biogenesis, RNA editing and splicing (Figure 4). A shared mechanism through which exapanded 17 
repeats elicit pathological consequences in SCA8, DM1, FXTAS and FTD-ALS is their induction of 18 
“Repeat-associated non-ATG translation” (RAN), whereby mRNA (both sense and antisense) 19 
translation in all three reading frames occurs within the repeats themselves, yielding toxic dipeptides 20 
(Figure 4). Lastly, transcription through expanded repeats may lead to the accumulation of R-loops 21 
(persistent RNA-DNA hybrids between the nascent RNA and DNA template), which causes abortive 22 
transcription and the induction of a DNA damage response. 23 
Type 2 MRDs  24 
In type 2 diseases, triplet repeat expansions occur exclusively in coding exons and hence they alter 25 
protein sequence by increasing the length of homopolymeric amino acid runs, typically polyglutamine 26 
and polyalanine (Table 2; Brouwer et al., 2009; Lopez Castel et al., 2010). Homopolymeric amino 27 
acid runs contribute to ‘protein disorder’, a structural property that often plays a critical role in 28 
mediating protein–protein and protein–DNA interactions, particularly in protein families comprising 29 
transcription factors and regulators of transcription and DNA replication (Uversky et al., 2009). 30 
Expansion beyond a critical threshold destabilises protein structure, causing aggregation or loss of the 31 
binding affinities with partner molecules (Messaed and Rouleau, 2009). 32 
The number of tandem repeats at a given locus is often polymorphic in the general population 33 
(variable number of tandem repeats or VNTR), a process that may be driven by slipped hairpins or 34 
aberrant DNA replication. The presence of a VNTR within an intron or the regulatory region of a 35 
14 
 
gene is often associated with a change in its transcription, thereby yielding functionally different 1 
alleles that may contribute to variable phenotypic traits (e.g. blood pressure, heart rate and muscular 2 
tension) and susceptibility to multigenic diseases, such as brain disorders, obesity and stroke (Bacolla 3 
et al., 2008; Hannan, 2010). Thus, slipped DNA may also contribute to phenotypic variability and 4 
susceptibility to disease. See also Chromosomal Genetic Disease: Structural Aberrations, and 5 
Segmental Duplications and Genetic Disease 6 
Non-B DNA/RNA and Cancer 7 
Non-B DNA structures have been suggested to contribute to chromosomal rearrangements 8 
(translocations and deletions) in cancer genomes. An analysis of ~20,000 translocation and ~46,000 9 
deletion breakpoints revealed that the chance of finding a non-B DNA-forming repeat within 500 bp 10 
of these sites before any rearrangement occurred was greater than expected by chance, and that the 11 
number of non-B DNA-forming repeats peaked exactly at breakpoints. These results were interpreted 12 
to mean that rearrangements were promoted by the formation of non-B DNA structures, possibly 13 
following their recognition and cleavage by DNA repair proteins or other nucleases (Bacolla et al., 14 
2016; Figure 5). Array CGH also indicated an overrepresentation of non-B DNA-forming repeats in 15 
the proximity of DNA breaks of somatic copy number alterations in osteaosarcoma (Smida et al., 16 
2017).  17 
Activation of translation has emerged as a potent inducer of oncogenic transformation. A key factor in 18 
the activation process, which is required for leukaemia maintenance, is eIF4A, an RNA helicase that 19 
recognizes a subset of genes, including transcription factors and oncogenes, through RNA G4 20 
structures in 5 UTRs. If not resolved these structures inhibit translation, and inhibition of translation 21 
by silvestrol and other agents that target eIF4A reduced the expresion levels of MYC, MYB, NOTCH, 22 
CDK6, BCL2 and other oncogenes (Wolfe et al., 2014). The relevance of RNA G4 structures in 23 
blocking translation was also highlighted by the fact that mice knockout for DHX36, which encodes 24 
the RNA G4 resolvase RHAU, was embryonic lethal due to severe heart defects (Nie et al., 2015). 25 
Overall, an increasing number of non-B DNA/RNA structure resolvases are being reported, which 26 
unwind DNA and RNA secondary structures and enable the progression of DNA replication, RNA 27 
transcription and translation complexes, and whose mutations are associated with human disease and 28 
cancer. Examples include ATRX, BLM, CHL1, CSA, CSB, DHX9, DNA2, FANCJ, PIF1, RTEL1, 29 
XPB, XPD, XRCC1-XPF and WRN (Barthelemy et al., 2016; Gray et al., 2014; Jiain et al., 2013; Lu 30 
et al., 2015; Maizels, 2015; Paeschke et al., 2013; Scheibye-Knudsen et al., 2016). As mentioned, 31 
lncRNAs are emerging as powerful repressors of gene expression in part by forming DNA:RNA 32 
triplexes, and by recruiting chromatin repressive complexes, such as the polycomb repressive 33 
complex 2 (PRC2) and modified histones (H3K27me3 and H3K9me3) (Mondal et al., 2015; Grote 34 
and Herrmann, 2013). From 17 gene expression studies representing 2,999 primary breast tumors, the 35 
15 
 
lncRNA MEG3 levels were on average the lowest, and MEG3 expressed at low levels in high-grade 1 
breast tumours (Mondal et al., 2015), suggesting that insufficient gene repression by lncRNA-2 
mediated RNA:DNA triplexes contributes to tumorigenesis. 3 
 4 
In summary, the formation of aberrant DNA secondary structure is the root cause of a number of quite 5 
different human inherited diseases, where mutagenesis is elicited in various ways: DNA breakage and 6 
stimulation of recombination leading to genomic rearrangements, altered RNA secondary structure, 7 
mRNA codon changes resulting in impaired protein function and altered transcription affecting 8 
protein levels. See also Trinucleotide Repeat Expansions: DisordersIn summary, the formation of 9 
DNA and RNA secondary structures contribute to a number of quite distinct human pathologies, 10 
where mutagenesis is elicited in various ways: DNA breakage and stimulation of recombination 11 
leading to genomic rearrangements, altered RNA secondary structure, mRNA codon changes resulting 12 
in impaired protein function, and altered transcription and translation affecting protein levels. See also 13 
Causes and Consequences of Structural Genomic Alterations in the Human Genome; Chromosomal 14 
Genetic Disease: Structural Aberrations, and Segmental Duplications and Genetic Disease; 15 
Identifying Genes Underlying Human Inherited Disease; Microsatellites; Mechanisms of RNA-16 
Induced Toxicity in Diseases Characterised by CAG Repeat Expansions; Trinucleotide Repeat 17 
Expansions: Disorders; Gene Structure and Organization; DNA Helicases; DNA Helicase-deficiency 18 
Disorders; The Transcription/DNA Repair Factor TFIIH; mRNA Untranslated Regions (UTRs); 19 
Protein Synthesis in Neurons. 20 
 21 
Mechanisms Underlying Non-B DNA- and RNA-22 
structure Induced Mutations Diseases 23 
A large number of studies have been conducted in model organisms, including bacteria, fly, yeast, 24 
mammalian cell culture and mice to address the mechanisms responsible for non-B DNA-induced 25 
genetic instability, particularly in the context of repeat expansion related to MRDs. Knocking down 26 
the expression of proteins involved in DNA replication, repair and recombination affected repeat 27 
stability by either increasing or decreasing instability (depending on the specific enzyme), suggesting 28 
that these biochemical processes are all potentially involved (Lopez Castel et al., 2010; Mirkin, 2007; 29 
Wells and Ashizawa, 2006; Polleys et al., 2017). Despite these important advances, the mechanisms 30 
restricting the timing of repeat instability and genomic rearrangements to early development remain 31 
elusive. In transgenic mice, the presence of Msh2 and Msh3, two proteins of the mismatch repair 32 
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pathway, was found to be critical for eliciting microsatellite repeat expansion during all stages of 1 
development (Figure 5; Dion and Wilson, 2009Zhao et al., 2015). A role restricted to adult somatic 2 
tissues has been noted for ataxia talangiectasia and Rad3 related (Atr), post-meiotic segregation 3 
increased 2 (Pms2) and the Ogg1 glycosylase. Atr, Pms2 and Ogg1 are involved in DNA damage 4 
responses and DNA repair. Thus, both DNA damage and DNA repair may play a critical role in 5 
eliciting non-B DNA-induced genetic instability, at least in the context of MRDs.  (Dion and Wilson, 6 
2009). 7 
<FIGURE 5 NEAR HERE> 8 
Concerning genomic rearrangements, classic and alternative nonhomologous end-joining (NHEJ), a 9 
DSB repair pathways that can be error-prone is are believed to act on DSBs induced at sites of non-B 10 
DNA structures (Kha et al., 2010).  11 
Numerous studies support an intimate connection between unresolved non-B DNA structures and 12 
genomic instability. For example, These DSBs are likely to result from the exposure, on non-B DNA 13 
formation, of single-stranded nucleotides to oxidative damage by endogenous reactive oxygen species 14 
or the activity of single-stranded-specific endonucleases. TOP1, which releaves negative supercoiling 15 
(negative supercoiling promotes non-B DNA), is recruited to chromatin by BRG1 (product of the 16 
SMARCA4 gene), a component of the SWI/SNF chromatin remodeler complex, and FACT, a two-17 
protein complex asssociated directly with histones. siRNA knock down of either TOP1 or SMARCA4 18 
increased translocation frequencies dramatically in B-cells ??? (Husain et al., 2016). In the context of 19 
CS, the accumulation of non-B structures in mitochondrial DNA appears to stall rDNA transcription 20 
and to lead to persistent activation of a DNA damage response which, orchestrated by PARP1, results 21 
in NAD+ depletion and increased lactate production (Scheibye-Knudsen et al., 2016). Unresolved 22 
CTG/CAG hairpin structures in FANCJ deficient cells led to loss of PCR amplifyiable genomic 23 
fragments, likely due to gross rearrangements, at loci associated with developmental disorders and 24 
cancer (Barthelemy et al., 2016). Fancj-null mice, in addition to displaying increased susceptibility to 25 
epitelial tumors and intrastrand crosslinking agents, also exhibited increased microsatellite instability 26 
(Matsuzaki et al., 2015). These composite observations support a role for FANCJ in resolving non-B 27 
DNA structures during DNA replication and the involvement of its mutations in human cancer. 28 
See also Trinucleotide Repeat Expansions: Mechanisms and Disease Associations; Mechanisms of 29 
Chromosome Translocations in Cancer; Genomic Rearrangements: Mutational Mechanisms. 30 
Prospects for the Future  31 
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The relevance of unusual or aberrant DNA structures to human genetic disease has extended our the 1 
interest in this area from the narrow confines of the nucleic acid biochemistry/physicochemical 2 
laboratory to a much wider community operating in medicine, clinical diagnostics, genetics and 3 
bioinformatics, thereby propelling the field into mainstream biomedical research. 4 
Paradoxically,Although the transient nature of DNA secondary structures remains a challenge,  for the 5 
development of non-B DNA structure-specific antibodies and ChIP-seq technology is expected to 6 
better define the landscape of non-B DNA structures methods aimed at identifying non-B DNA 7 
structures in living human cells. 8 
The advent of aCGH is likely to reveal more instances of the co-localisation of repetitive DNA with 9 
CNVs, both in the context of phenotypic variation, as well as in the sphere of susceptibility to 10 
infectious disease, cancer and inherited disease. As more information is acquired from mouse models 11 
on the timing of repeat instability during development and its relationships with chromatin 12 
remodelling, CpG methylation-linked epigenetic reprogramming, and DNA damage and repair, 13 
experiments can be designed to further address the biochemical pathways involved in non-B-directed 14 
genetic instability. Strong advances have been made that highlighted biological roles for non-B 15 
DNA/RNA structures, and future studies are expected that will probe the spectrum of non-B DNA and 16 
RNA biological roles. Likewise, the number of enzymes interacting with non-B DNA and RNA has 17 
increased considerably, which is revealing more intimate connections between non-B structures and 18 
human pathology.  19 
SConsiderable effort is currently being invested in sequencing cancer genomes was . This information 20 
will be crucial to address the question as to whether non-B DNA is also responsible for at least some 21 
of the genomic rearrangements associated with cancer. As larger cancer genome datasets will be 22 
available, it will be possible to assess the quantitative contribution of non-B DNA to mutational loads 23 
in cancer. The formation of triplex DNA through the delivery of triplex-forming oligonucleotides 24 
(TFOs) is being pursued with the aim of knocking-down gene expression or directly inactivating 25 
target genes (Jain et al., 2008). This technology has the potential to complement the arsenal of tools 26 
currently used to combat cancer. Finally, studies aimed at developing reagents that can identify non-B 27 
DNA structures in cells are ongoing. Major advances are therefore to be expected in the coming years.  28 
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imply endorsement by the U.S. Government. 3 
Glossary 4 
aCGH 5 
Array comparative genomic hybridisation (a technique used to detect genomic copy 6 
number variations at a high resolution). 7 
CNV 8 
Copy number variant (segment of DNA that exhibits copy-number differences when 9 
two or more genomes are compared). 10 
Microsatellites 11 
Simple sequence repeats that contain sequences of 1–6 base pairs of DNA. 12 
Non-B DNA 13 
DNA structures, distinct from the canonical B-form, including left-handed Z-DNA, 14 
cruciforms, looped-out or slipped folds, parallel DNA, triplexes and quadruplexes. 15 
VNTR 16 
A location in the genome where a short nucleotide sequence is organised as a tandem 17 
repeat which displays variations in length between individuals. 18 
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 1 
 2 
Figure 1. Non-B DNA structures formed by genomic repetitive sequences. (a) Most common 3 
non-B DNA conformations, ribbon models of helical foldings, repetitive motifs requirement 4 
and example of sequences. Center dot, Watson–Crick hydrogen bond interactions; x,y, 5 
nucleotides in the spacer between repeats; L, lateral loop; D, diagonal loop and CR, chain 6 
reversal loop. For cruciform DNA, an extended conformation is shown. For triplex DNA, a 3′ 7 
29 
 
RRY isomer is depicted in which the 3′-half of the purine-rich strand folds back to form the 1 
Hoogsteen-bound third strand. For quadruplex DNA, an idealised structure is drawn to 2 
highlight the loop characteristics and the relative orientation of the syn and anti N-glycosidic 3 
configurations. (b) RRY base triplets showing the Hoogsteen-bound base (left). Thymine can 4 
be incorporated into RRY triplexes due to the symmetry of the carbonyl groups. (c) YRY 5 
base triplets showing the Hoogsteen-bound pyrimidine and the stabilisation afforded by 6 
cytosine protonation. (d) G-tetrad. 7 
Table 1. Non-B DNA-forming repeats and human genes. Most 
relevant repetitive DNA sequences associated with human genes or 
gene classes 
Gene/gene families in the largest (>100 kb) inverted repeats (IR) 
Chromosome 
IR arm 
size (kb) 
Gene/gene 
class 
Tissues with 
predominant 
expression 
Y palindrome P1 1450 DAZ Testes 
Y palindrome P5 495.5 CDY Testes 
Y palindrome P3 283.0 PRY Testes 
Y palindrome P4 190.2 HSFY Testes 
Xp11.22 142.2 GAGE-D2,3 Testes 
Xq22.1 140.6 NXF2 Testes 
Y palindrome P2 122.0 DAZ Testes 
Xq13.1 119.3 DMRTC1 Testes, kidney, pancreas 
11q14.3 103.9 RNF18 Testes, kidney, spleen 
        
Purine:pyrimidine tracts in introns of genes 
Gene category/function P-value   
  
≥250 nt (228 
genes) 
≥100 nt (1951 
genes) 
Ion channel activity 1.95×10−05 5.92×10−09 
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Purine:pyrimidine tracts in introns of genes 
Gene category/function P-value   
Protein binding 3.14×10−03 6.25×10−15 
Glutamate receptor activity 6.11×10−04 1.92×10−07 
Cell adhesion 1.11×10−04 3.36×10−12 
Cell communication 2.19×10−04 5.24×10−15 
Transmission of nerve 
impulse 
1.83×10−04 5.24×10−08 
Synapse 2.18×10−02 7.69×10−05 
Alternative splicing ND 2×10−82 
Chromosomal translocations ND 1×10−07 
      
Tetranucleotide repeats (TR) in introns of genes 
Gene 
category/function/attribute 
P-value   
Localisation to the 
membrane 
1×10−07–
5×10−30 (Range for 10 gene groups 
containing: groups 1–8, 8–15 
TR units; group 9, 16 and 17 
TR units; group 10, ≥18 TR 
units; 190–1423 genes/group) 
Ion channel 
5×10−02–
1×10−13 
Cell adhesion 
8×10−04–
2×10−37 
Alternative splicing 1×10−64 ≥8TR units (4182 genes) 
Chromosomal translocations 2×10−07 ≥8TR units (4182 genes) 
      
31 
 
Micro/minisatellites (2–11 nt repeats) in cDNAs 
Gene category/function 
P-value (coding plus noncoding 
exons) (2626 genes) 
Transcription regulator activity 2.0×10−40 
Regulation of cellular processes 2.3×10−38 
Protein binding 2.0×10−33 
Sequence-specific DNA binding 3.8×10−23 
Nuclear localisation 9.3×10−22 
RNA polymerase II transcription 
factor activity 
1.2×10−16 
Axon guidance 2.3×10−05 
MAPK signalling pathway 2.1×10−04 
WNT signalling pathway 2.4×10−04 
    
G-quadruplex in both 5′- and 3′-UTR 
Gene category/function P-value   
1. Note: ND, not determined. 
2. a 
Source: With kind permission from Springer Science+Business Media 
(Zhao et al., 2010). 
  5′-UTR 3′-UTR 
Guanyl-nt exchange factor activity 7.9×10−13 6.3×10−12 
Rho guanyl-nt exchange factor activity 7.9×10−10 1.6×10−09 
Regulation of Rho signal transduction 2.0×10−10 1.6×10−09 
Transcription factor activity 6.3×10−05 3.2×10−10 
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G-quadruplex in both 5′- and 3′-UTR 
Gene category/function P-value   
Sequence-specific DNA binding 2.5×10−06 3.2×10−08 
Quadruplex-forming motifs are strongly over-represented near (±500 bp) transcription start sites and at the 3′ end of genes 1 
(1/4 to 1/3 of ∼20 000 human genes) associated with regulatory functions, including proto-oncogenes, such as MYC, KRAS 2 
and KIT (Du et al., 2008; Huppert et al., 2008; Table 1). Genome-wide gene expression analyses (Du et al., 2008; Fernando 3 
et al., 2009) support the conclusion that these sequences play an active role in transcriptional regulation through the 4 
formation of quadruplex structures (Figure 2a). 5 
33 
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Figure 2. Non-B DNA-forming repeats and genome-wide gene expression. (a) The gene 1 
expression profile of 13 237 nonredundant annotated human (RefSeq) genes (y-axis) was 2 
examined in 79 tissues/cancer/cell types (x-axis) and the average values plotted for the 8124 3 
genes that contained quadruplex-forming repeats (filled squares) within ±500 base pairs of 4 
the main transcription start site (TSS) and the remaining genes that did not contain such 5 
elements within ±500 base pairs of the main TSS (open squares). (b) The gene expression 6 
levels for 16 146 gene probes in the 70 human tissues/cell types included in (a) was plotted as 7 
percent of data (y-axis) falling within specific intervals of gene expression (x-axis) for control 8 
genes (black) and for 190 genes (red) that contained triplex-forming tetranucleotide repeats 9 
≥72 base pairs long. With kind permission from Springer Science+Business Media (Zhao et 10 
al., 2010). 11 
 12 
 13 
Figure 32. Cruciform-mediated chromosomal t(11;22) translocation and the Emanuel 14 
syndrome. The PATRR sequences on human chromosome 11 (green) and 22 (black) are 15 
proposed to fold into large cruciform structures at some frequency during gametogenesis and 16 
be cleaved at the single-stranded tips, resulting in double-strand breaks (left insets). The 17 
broken chromosomal ends (middle) join aberrantly, yielding the derivative chromosomes 18 
der(11) and der(22) (right). Occasional inheritance of der(22), in addition to a normal 19 
karyotype, is responsible for the Emanuel syndrome in the offspring. 20 
 21 
 22 
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Table 2. Microsatellite repeat diseases (MRDs). Type 1 and type 2 
microsatellite repeat diseases 
Disease Gene 
Chrom
osome 
locatio
n 
Amplet 
Nor
mal 
cop
y 
leng
th 
or 
nu
mbe
r 
Expa
nded 
copy 
lengt
h or 
num
ber 
Loca
tion 
Dise
ase 
sym
bol 
1. Source: With kind permission from Springer Science+Business 
Media (Zhao et al., 2010). 
Type 1 diseases 
FRAXE-
associated 
mental 
retardation 
AFF2 Xq28 CCG 
4–
39 
>200 
5′-
UTR 
FRA
XE 
Spinocere
bellar 
ataxia 10 
ATXN
10 
22q13.3
1 
ATTCT <29 >800 
Intro
n 1 
SCA
10 
Spinocere
bellar 
ataxia 8 
ATXN
8OS 
13q21 CTG 
15–
50 
110–
130 
3′-
UTR 
SCA
8 
Jacobsen 
syndrome 
CBL2 11q23.3 CCG 11 
700–
800 
? 
FRA
11B 
Myotonic 
dystrophy 
type 2 
CNBP 3q21 CCTG 
104
–
176 
bp 
75–
11 00
0 
Intro
n 1 
DM
2 
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Table 2. Microsatellite repeat diseases (MRDs). Type 1 and type 2 
microsatellite repeat diseases 
Disease Gene 
Chrom
osome 
locatio
n 
Amplet 
Nor
mal 
cop
y 
leng
th 
or 
nu
mbe
r 
Expa
nded 
copy 
lengt
h or 
num
ber 
Loca
tion 
Dise
ase 
sym
bol 
Epilepsy 
progressiv
e 
myoclonic 
CSTB 21q2.3 
CCCCGC
CCCGCG 
2–3 
30–
75 
Pro
mote
r 
EPM
1 
Mental 
retardation 
DIP2
B 
12q13.1
3 
CGG 
6–
23 
250–
285 
5′-
UTR 
FRA
12A 
Myotonic 
dystrophy 
type 1 
DMP
K 
19q13.3
2 
CTG <30 
50–
2000 
3′-
UTR 
DM
1 
Fragile X 
mental 
retardation 
syndrome 
FMR1 Xq27.3 CGG 
5–
52 
>200 
5′-
UTR 
FXS 
Fragile X-
associated 
tremor 
ataxia 
syndrome 
FMR1 Xq27.3 CGG <55 
55–
200 
5′-
UTR 
FXT
AS 
Friedreich 
ataxia 
FXN 9q21.11 GAA 
7–
20 
200–
900 
Intro
n 1 
FA 
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Table 2. Microsatellite repeat diseases (MRDs). Type 1 and type 2 
microsatellite repeat diseases 
Disease Gene 
Chrom
osome 
locatio
n 
Amplet 
Nor
mal 
cop
y 
leng
th 
or 
nu
mbe
r 
Expa
nded 
copy 
lengt
h or 
num
ber 
Loca
tion 
Dise
ase 
sym
bol 
Spinocere
bellar 
ataxia 12 
PPP2
R2B 
5q32 CAG 
7–
31 
55–
78 
5′-
UTR 
SCA
12 
Cataract 
formation 
in 
myotonic 
dystrophy 
SIX5 
19q13.3
2 
CTG 
5–
37 
≥50 
Pro
mote
r 
SIX
5 
Spinocere
bellar 
ataxia 31 
TK2/
BEAN 
16q22 TGGAA 0 110 
Intro
n 
SCA
31 
                
Type 2 diseases 
Spino-
bulbar 
muscular 
atrophy 
(Kennedy 
disease) 
AR Xq12 CAG 
17–
26 
40–
52 
Codi
ng 
regio
n 
SB
MA 
Mental 
retardation 
ARX Xp21.3 GCG 
10–
16 
17–
33 
Exon 
1 
XL
MR 
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Table 2. Microsatellite repeat diseases (MRDs). Type 1 and type 2 
microsatellite repeat diseases 
Disease Gene 
Chrom
osome 
locatio
n 
Amplet 
Nor
mal 
cop
y 
leng
th 
or 
nu
mbe
r 
Expa
nded 
copy 
lengt
h or 
num
ber 
Loca
tion 
Dise
ase 
sym
bol 
and 
epilepsy 
Dentatoru
bro-
pallidoluy
sian 
atrophy 
(Haw river 
fever) 
ATN1 
12p13.3
1 
CAG 
3–
36 
48–
93 
Codi
ng 
regio
n 
DRP
LA 
Spinocere
bellar 
ataxia 1 
ATXN
1 
6p22.3 CAG 
6–
44 
37–
91 
Codi
ng 
regio
n 
SCA
1 
Spinocere
bellar 
ataxia 2 
ATXN
2 
12q24.1
2 
CAG 
14–
31 
32–
500 
Codi
ng 
regio
n 
SCA
2 
Machado–
Joseph 
disease 
ATXN
3 
14q32.1
2 
CAG 
13–
47 
53–
86 
Codi
ng 
regio
n 
SCA
3 
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Table 2. Microsatellite repeat diseases (MRDs). Type 1 and type 2 
microsatellite repeat diseases 
Disease Gene 
Chrom
osome 
locatio
n 
Amplet 
Nor
mal 
cop
y 
leng
th 
or 
nu
mbe
r 
Expa
nded 
copy 
lengt
h or 
num
ber 
Loca
tion 
Dise
ase 
sym
bol 
Spinocere
bellar 
ataxia 7 
ATXN
7 
3p14.1 CAG 
7–
35 
36–
300 
Codi
ng 
regio
n 
SCA
7 
Spinocere
bellar 
ataxia 6 
CAC
NA1A 
19p13.1
3 
CAG 
4–
18 
19–
33 
Codi
ng 
regio
n 
SCA
6 
Blepharop
himosis 
syndrome 
and 
premature 
ovarian 
failure 3 
FOXL
2 
3q22.3 GCN 14 
22–
24 
Codi
ng 
regio
n 
BPE
S 
Hand-
foot-
genital 
syndrome 
HOX
A13 
7p15.2 GCN 
14–
18 
22–
30 
Codi
ng 
regio
n 
HFG
S 
Brachydac
tyly 
HOX
D13 
2q31.1 GCN 15 
22–
29 
Codi
ng 
SPD 
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Table 2. Microsatellite repeat diseases (MRDs). Type 1 and type 2 
microsatellite repeat diseases 
Disease Gene 
Chrom
osome 
locatio
n 
Amplet 
Nor
mal 
cop
y 
leng
th 
or 
nu
mbe
r 
Expa
nded 
copy 
lengt
h or 
num
ber 
Loca
tion 
Dise
ase 
sym
bol 
syndactyly 
syndrome 
regio
n 
Huntingto
n disease 
HTT 
4p16.3–
4p16.2 
CAG <35 
40–
400 
Codi
ng 
regio
n 
HD 
Huntingto
n disease-
like 2 
JPH3 16q24.2 CTG 
6–
27 
44–
57 
Exon 
1 
HDL
2 
Oculophar
yngeal 
muscular 
dystrophy 
PABP
N1 
14q11.2 GCG 6 7–13 
Codi
ng 
regio
n 
OP
MD 
Congenital 
central 
hypoventil
ation 
syndrome 
PHO
X2B 
4p13 GCN 20 
25–
33 
Codi
ng 
regio
n 
CCH
S 
Cleidocran
ial 
dysplasia 
RUN
X2 
6p12.3 GCK 17 27 
Codi
ng 
regio
n 
CCD 
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Table 2. Microsatellite repeat diseases (MRDs). Type 1 and type 2 
microsatellite repeat diseases 
Disease Gene 
Chrom
osome 
locatio
n 
Amplet 
Nor
mal 
cop
y 
leng
th 
or 
nu
mbe
r 
Expa
nded 
copy 
lengt
h or 
num
ber 
Loca
tion 
Dise
ase 
sym
bol 
Spinocere
bellar 
ataxia 17 
TBP 6q27 CAG 
25–
42 
45–
63 
Codi
ng 
regio
n 
SCA
17 
Holoprose
ncephaly 
ZIC2 13q32.3 GCN 15 25 
Codi
ng 
regio
n 
HPA 
 1 
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 1 
Figure 34. Triplet repeat expansion alters mRNA function. (a) In DM1, CTG expansion in the 2 
3′-UTR of the DMPK gene causes the ensuing mRNA to fold into a large and stable double-3 
stranded hairpin stabilised by U•U and G•C base pairs, which recruits muscleblind-like 4 
(Drosophila) (MBNL1), a mediator of pre-mRNA alternative splicing regulation. CUG-5 
hairpins also stimulate CUG RNA-binding protein 1 (CUGBP1) hyperphosphorylation and 6 
stabilisation, which alter several events related to alternative splicing, mRNA tanslation and 7 
mRNA decay. (b) Sequestration of MBNL1 and CUGBP1 activation shift alternative splicing 8 
programs from the adult stage towards embryonic-specific patterns, including activation of 9 
43 
 
exon 5 inclusion of cardiac isoforms of TNNT2 (cTNT) during heart remodeling, exclusion 1 
of exon 11 in the insulin receptor (IR) pre-mRNA and inclusion of stop-containing exon in 2 
chloride channel 1 transcripts. Adapted from Lee and Cooper 2009 with kind permission by 3 
Portland Press Ltd. Copyright © the Biochemical Society. 4 
 5 
 6 
Figure 4. Gain-of-function by expanded G4 DNA-forming repeats at the C9orf72 locus. (a) 7 
The C9orf72 gene is transcribed from two alternative transcription start sites (TSSs; Ex 1b 8 
and Ex 1a) in three gene isoforms. The G4C2 repeats is located in intron 1 (white boxes, 9 
UTRs; gray boxes, coding exons; thin lines, introns) on the non-transcribed strand (thus it is 10 
present on the sense RNA) between Ex 1a and Ex 1b. (b) Normal alleles containing 2-8 G4-11 
forming repeats are transcribed normally (top). In expanded alleles (bottom) transcription is 12 
reduced. The non-transcribed strand forms an “island” of antiparallel G4 structures. The 13 
transcribed strand yields sense RNA with multiple parallel G4 DNA structures. Antisense 14 
transcription also takes place through the island, yielding antisense RNAs with potential 15 
secondary structures. (c) The aberrant transcripts sequenster RNA-binding proteins, forming 16 
nuclear protein-RNA foci (left); they also bind nucleolin in nucleoli, where they prevent 17 
44 
 
biogenesis of new ribosomal RNAs (rRNA; right). (d) Once transported to the cytoplasm, 1 
both sense and antisense transcripts undergo RAN translation in all three possible reading 2 
frames, thereby producing dipeptide repeat proteins (DPR) prone to aggregation in the 3 
cytoplasm, nucleus and the nucleolus. Reproduced with permision from Simone et al., 2015. 4 
 5 
 6 
Figure 5. Translocation and deletion breakpoints occur near non-B DNA-forming sequences in cancer 7 
genomes. (a) Schematic of a 1kb interval (bin) with the site of rearrangement (breakpoint) at the 8 
centre and 500 bps of flanking DNA sequence. The genomic location at each breakpoint identified in 9 
cancer patients by high-throughput whole-genome DNA sequencing and resolved at bp resolution was 10 
first mapped to the human reference genome, and 500 bps on either side of each breakpoint were 11 
sought for the occurrence of non-B DNA-forming sequences. (b) Number of triplex DNA-forming 12 
repeats. (c) Number of inverted repeats. (d) Number of direct (tandem) repeats. (e) Number of G4 13 
DNA-forming repeats. (f) Number of Z-DNA forming repeats. Contr1, 20,222 randomly generated 14 
sites throughout the human genome; Trans, 19,947 chromosomal translocation breakpoints; Delet, 15 
46,365 deletion breakpoints. In most cases the number of non-B DNA-forming repeats peaked at the 16 
breakpoint position, implying their involvement in triggering DNA strand breaks that may have 17 
elicited the genomic rearrangements. With kind permission from Oxford University Press (Bacolla et 18 
al., 2016).  19 
Figure 5. Modulators of triplet repeat expansion in mouse models of MRDs. The mismatch repair 20 
proteins Msh2 and Msh3 are required for triplet repeat instability throughout all developmental 21 
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stages. DNA cytosine-5-methyltransferase 1 (Dnmt1) protects against expansions in an expanded 1 
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